Document is current
Any future updates will be listed below
-
Authors
Tahedl, Marlene
Levine, Seth M.
Weissert, Robert
Kohl, Zacharias
Lee, De-Hyung
Linker, Ralf A.
Schwarzbach, Jens V. https://orcid.org/0000-0002-0303-6979
-
Funding
Funding for this research was provided by:
Deutschen Multiple Sklerose Gesellschaft (2018_DMSG_08)
- License Information
-
More Information
Article History
Received: 8 April 2022
Accepted: 6 August 2022
First Online: 27 October 2022
Change Date: 19 January 2023
Change Type: Update
Change Details: Incorrect Funding note.
Declarations
:
: All patients provided written informed consent to participate in this study. All study procedures followed safety guidelines for MRI research at the University of Regensburg, complied with the 1964 Helsinki Declaration and its later amendments, and were approved by the ethics committee of the University of Regensburg.
: Not applicable.
: MT, SML, RW, ZK, and JVS declare no conflicts of interest. RAL and DHL received compensation for activities with Bayer, Biogen, Celgene, Genzyme, Merck, Novartis, Roche and TEVA as well as research support from Merck and Novartis.
